Need Help?

Additional RNA-seq, ChIP-seq, and ATAC-seq files for PCGP SJERG

This dataset contains RNA-seq, ATAC-seq, and ChIP-seq samples from the SJERG cohort. We applied ChIP-Seq for Dux4 on two B-cell ALL cell-lines(REH, Nalm6) along with INPUT. ATAC-Seq on two B-cell ALL cell-lines(REH, Nalm6) and xenograft of a B-cell ALL patient(ERG000016).

Request Access

DAC to obtain datasets submitted by St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Learn more about the PCGP, disease types, publications, the PCGP Data Access Committee, and instructions to access data via EGA: https://pecan.stjude.cloud/permalink/pcgp Complete the attached Data Access Agreement (DAA), adhering to the following guidance, and return it to pcgpdaccoordinator@stjude.org: - Requests must be made for individual datasets (EGAD ID), not full studies (EGAS ID). - A separate DAA must be submitted for each dataset AND all original pages must be included. - The first listed applicant should be the Principal Investigator, Head of Department, or Department Chair leading the project. This should not be a staff scientist or postdoctoral researcher. - The email address used to access the dataset(s) must be a work-related email, not a personal email. - The signature of the “Institutional or Administrative Authority” must be an individual with the authority to sign documents on behalf of the requesting institution. This individual is known as the Authorized Organizational Representative (AOR) and is typically someone in the requesting institution's legal department or grants office. Heads/Chairs of Departments cannot sign as the Institutional or Administrative Authority. - Not adhering to these policies will delay your application. Once we receive your completed application, the DAC review typically takes approximately 15-20 business days. - If we do not receive a completed DAA from you within 90 days, we will consider this application closed and reject your request in the EGA portal. You may resubmit later as needed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001001923 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00001280496 bam 27.0 GB
EGAF00001280497 bam 5.6 GB
EGAF00001280498 bam 8.2 GB
EGAF00001280499 bam 2.2 GB
EGAF00001280500 bam 2.2 GB
EGAF00001280501 bam 11.3 GB
EGAF00001280502 bam 5.7 GB
EGAF00001280503 bam 3.5 GB
EGAF00001280504 bam 5.8 GB
EGAF00001280505 bam 2.2 GB
EGAF00001280506 bam 2.3 GB
EGAF00001280507 bam 2.1 GB
EGAF00001280510 bam 3.1 GB
EGAF00001280511 bam 3.7 GB
EGAF00001280512 bam 5.0 GB
EGAF00001280513 bam 4.9 GB
EGAF00001280514 bam 4.8 GB
EGAF00001280515 bam 4.9 GB
EGAF00001280516 bam 4.9 GB
EGAF00001280517 bam 4.9 GB
EGAF00001280518 bam 4.9 GB
EGAF00001280519 bam 2.6 GB
EGAF00001280520 bam 3.2 GB
EGAF00001280521 bam 4.5 GB
EGAF00001280522 bam 4.5 GB
EGAF00001280523 bam 4.5 GB
EGAF00001280524 bam 4.5 GB
EGAF00001280525 bam 4.5 GB
EGAF00001280526 bam 4.5 GB
EGAF00001280527 bam 4.5 GB
EGAF00001280531 bam 29.4 GB
31 Files (185.8 GB)